{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:16:37Z","timestamp":1793132197851,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["PCT\/US21\/46904"],"award-info":[{"award-number":["PCT\/US21\/46904"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CFF GOEDEN19F0"],"award-info":[{"award-number":["CFF GOEDEN19F0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["W911NF-17-2-0036"],"award-info":[{"award-number":["W911NF-17-2-0036"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP1OD025535"],"award-info":[{"award-number":["DP1OD025535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.omtm.2022.07.010","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T11:59:48Z","timestamp":1659355188000},"page":"331-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-1697","authenticated-orcid":false,"given":"David","family":"Goertsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Goeden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Flytzanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-348X","authenticated-orcid":false,"given":"Viviana","family":"Gradinaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2022.07.010_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.omtm.2022.07.010_bib2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.gt.3302766","article-title":"Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice","volume":"13","author":"Rivi\u00e8re","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtm.2022.07.010_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOL.0b013e3283555a7e","article-title":"Gene therapy for lipoprotein lipase deficiency","volume":"23","author":"Gaudet","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.omtm.2022.07.010_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","article-title":"The clinical landscape for AAV gene therapies","volume":"20","author":"Kuzmin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2022.07.010_bib6","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1002\/jgm.3015","article-title":"Gene therapy clinical trials worldwide to 2017: an update","volume":"20","author":"Ginn","year":"2018","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2022.07.010_bib7","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1038\/sj.gt.3302368","article-title":"Gene therapy for cystic fibrosis: an example for lung gene therapy","volume":"11","author":"Griesenbach","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mt.2008.217","article-title":"Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of \u03b1-1-antitrypsin using invasive and noninvasive delivery","volume":"17","author":"Liqun Wang","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib9","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3390\/ijms22052566","article-title":"The history and mystery of alveolar epithelial type II cells: focus on their physiologic and pathologic role in lung","volume":"22","author":"Ruaro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2022.07.010_bib10","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3390\/ijms21072269","article-title":"Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis","volume":"21","author":"Parimon","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2022.07.010_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jcp.54.2.132","article-title":"Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)\/usual interstitial pneumonia (UIP)","volume":"54","author":"Barbas-Filho","year":"2001","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.omtm.2022.07.010_bib12","first-page":"6407","article-title":"Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib","volume":"9","author":"Bonella","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmed.2017.00118","article-title":"Exploring animal models that resemble idiopathic pulmonary fibrosis","volume":"4","author":"Tashiro","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.omtm.2022.07.010_bib14","doi-asserted-by":"crossref","first-page":"118166","DOI":"10.1016\/j.lfs.2020.118166","article-title":"The pathophysiology of SARS-CoV-2: a suggested model and therapeutic approach","volume":"258","author":"Morris","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.omtm.2022.07.010_bib15","doi-asserted-by":"crossref","first-page":"110412","DOI":"10.1016\/j.mehy.2020.110412","article-title":"Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: a physio-pathological theory","volume":"146","author":"Carcaterra","year":"2021","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.omtm.2022.07.010_bib16","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1073\/pnas.92.17.7794","article-title":"Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice","volume":"92","author":"Clark","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2022.07.010_bib17","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1073\/pnas.101500298","article-title":"Altered stability of pulmonary surfactant in SP-C-deficient mice","volume":"98","author":"Glasser","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2022.07.010_bib18","doi-asserted-by":"crossref","first-page":"L64","DOI":"10.1152\/ajplung.90640.2008","article-title":"Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection","volume":"297","author":"Glasser","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.omtm.2022.07.010_bib19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbrc.2007.05.219","article-title":"Targeted inactivation of the murine Abca3 gene leads to respiratory failure in newborns with defective lamellar bodies","volume":"359","author":"Hammel","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2022.07.010_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1194\/jlr.M600449-JLR200","article-title":"ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol","volume":"48","author":"Fitzgerald","year":"2007","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.omtm.2022.07.010_bib21","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMra022387","article-title":"Hydrophobic surfactant proteins in lung function and disease","volume":"347","author":"Whitsett","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2022.07.010_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.med.60.041807.123500","article-title":"Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease","volume":"61","author":"Whitsett","year":"2010","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omtm.2022.07.010_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-3476(97)70348-2","article-title":"Lung transplantation for treatment of infants with surfactant protein B deficiency","volume":"130","author":"Hamvas","year":"1997","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.omtm.2022.07.010_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2016.08.003","article-title":"In\u00a0vivo tissue-tropism of adeno-associated viral vectors","volume":"21","author":"Srivastava","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omtm.2022.07.010_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV vector immunogenicity in humans: a long journey to successful gene transfer","volume":"28","author":"Verdera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2022.07.010_bib27","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2022.07.010_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nbt1182","article-title":"Directed evolution of adeno-associated virus yields enhanced gene delivery vectors","volume":"24","author":"Maheshri","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2022.07.010_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1227\/NEU.0000000000000589","article-title":"Rational design and engineering of a modified adeno-associated virus (AAV1)-based vector system for enhanced retrograde gene delivery","volume":"76","author":"Davis","year":"2015","journal-title":"Neurosurgery"},{"key":"10.1016\/j.omtm.2022.07.010_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.omtm.2020.12.006","article-title":"Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning","volume":"20","author":"Nonnenmacher","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.07.010_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41592-020-0799-7","article-title":"Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types","volume":"17","author":"Ravindra Kumar","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2022.07.010_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2022.07.010_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.omtm.2020.10.010","article-title":"Directed evolution of AAV serotype 5 for increased hepatocyte transduction and retained low humoral seroreactivity","volume":"20","author":"Qian","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.07.010_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymthe.2017.09.021","article-title":"Bioengineered AAV capsids with combined high human liver transduction in\u00a0vivo and unique humoral seroreactivity","volume":"26","author":"Paulk","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.omtm.2020.09.019","article-title":"Engineering and in\u00a0vitro selection of a novel AAV3B variant with high hepatocyte tropism and reduced seroreactivity","volume":"19","author":"Biswas","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.07.010_bib36","doi-asserted-by":"crossref","first-page":"e64175","DOI":"10.7554\/eLife.64175","article-title":"scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution","volume":"10","author":"\u00d6zt\u00fcrk","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.omtm.2022.07.010_bib37","doi-asserted-by":"crossref","first-page":"135112","DOI":"10.1172\/jci.insight.135112","article-title":"In\u00a0vivo-directed evolution of adeno-associated virus in the primate retina","volume":"5","author":"Byrne","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2022.07.010_bib38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41467-018-08283-7","article-title":"Next-generation muscle-directed gene therapy by in\u00a0silico vector design","volume":"10","author":"Sarcar","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.07.010_bib39","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/mt.2011.22","article-title":"Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer","volume":"19","author":"Pulicherla","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.omtm.2018.04.005","article-title":"A novel triple-mutant AAV6 capsid induces rapid and potent transgene expression in the muscle and respiratory tract of mice","volume":"9","author":"van Lieshout","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.07.010_bib41","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1038\/s41467-020-17577-8","article-title":"A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency","volume":"11","author":"Kang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.07.010_bib42","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/mt.2016.62","article-title":"Pulmonary targeting of adeno-associated viral vectors by next-generation sequencing-guided screening of random capsid displayed peptide libraries","volume":"24","author":"K\u00f6rbelin","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib43","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1073\/pnas.0813365106","article-title":"Directed evolution of adeno-associated virus to an infectious respiratory virus","volume":"106","author":"Excoffon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2022.07.010_bib44","doi-asserted-by":"crossref","first-page":"e88728","DOI":"10.1172\/jci.insight.88728","article-title":"CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes","volume":"1","author":"Steines","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2022.07.010_bib45","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1165\/rcmb.2019-0006OC","article-title":"A novel AAV-mediated gene delivery system corrects CFTR function in pigs","volume":"61","author":"Cooney","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.omtm.2022.07.010_bib46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/gt.2017.75","article-title":"Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler\u2013Najjar Syndrome Type I","volume":"24","author":"Bo\u010dkor","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00341","article-title":"Humoral immune response to AAV","volume":"4","author":"Calcedo","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2022.07.010_bib48","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1128\/JVI.00209-12","article-title":"The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing","volume":"86","author":"Raupp","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.07.010_bib49","doi-asserted-by":"crossref","first-page":"13532","DOI":"10.1074\/jbc.M110.210922","article-title":"Terminal N-linked galactose is the primary receptor for adeno-associated virus 9","volume":"286","author":"Shen","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2022.07.010_bib50","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","article-title":"Identification of a heparin-binding motif on adeno-associated virus type 2 capsids","volume":"77","author":"Kern","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.07.010_bib51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000445646","article-title":"Tyrosine mutation in AAV9 capsid improves gene transfer to the mouse lung","volume":"39","author":"Martini","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.omtm.2022.07.010_bib52","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1073\/pnas.0802866105","article-title":"Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses","volume":"105","author":"Zhong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2022.07.010_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12896-015-0230-0","article-title":"Single point mutation in adeno-associated viral vectors -DJ capsid leads to improvement for gene delivery in\u00a0vivo","volume":"16","author":"Mao","year":"2016","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.omtm.2022.07.010_bib54","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1128\/JVI.07232-11","article-title":"Structural insight into the unique properties of adeno-associated virus serotype 9","volume":"86","author":"DiMattia","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.07.010_bib55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1525-0016(03)00123-0","article-title":"In\u00a0vitro selection of viral vectors with modified tropism: the adeno-associated virus display","volume":"8","author":"Perabo","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib56","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/12491","article-title":"Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2","volume":"5","author":"Girod","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2022.07.010_bib57","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/nbt856","article-title":"Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors","volume":"21","author":"M\u00fcller","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2022.07.010_bib58","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/gt.2009.59","article-title":"A muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery","volume":"16","author":"Yu","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib59","doi-asserted-by":"crossref","first-page":"e23101","DOI":"10.1371\/journal.pone.0023101","article-title":"Peptide ligands incorporated into the threefold spike capsid domain to Re-direct gene transduction of AAV8 and AAV9 in\u00a0vivo","volume":"6","author":"Michelfelder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2022.07.010_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2022.07.010_bib61","doi-asserted-by":"crossref","first-page":"730825","DOI":"10.3389\/fimmu.2021.730825","article-title":"Deep parallel characterization of AAV tropism and AAV-mediated transcriptional changes via single-cell RNA sequencing","volume":"12","author":"Brown","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2022.07.010_bib62","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/bbrc.1993.2045","article-title":"Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells","volume":"195","author":"Iwama","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2022.07.010_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/01902140303767","article-title":"A unique pattern of Tie1 expression in the developing murine lung","volume":"29","author":"Taichman","year":"2003","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.omtm.2022.07.010_bib64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature10413","article-title":"Mouse genomic variation and its effect on phenotypes and gene regulation","volume":"477","author":"Keane","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.07.010_bib65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12864-015-2291-9","article-title":"Complex regulation of ADAR-mediated RNA-editing across tissues","volume":"17","author":"Huntley","year":"2016","journal-title":"BMC Genom."},{"key":"10.1016\/j.omtm.2022.07.010_bib66","first-page":"106","article-title":"Timing and expression of the angiopoietin-1\u2013Tie-2 pathway in murine lung development and congenital diaphragmatic hernia","volume":"6","author":"Grzenda","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2022.07.010_bib67","doi-asserted-by":"crossref","first-page":"28272","DOI":"10.1038\/srep28272","article-title":"Ultramicroscopy as a novel tool to unravel the tropism of AAV gene therapy vectors in the brain","volume":"6","author":"Alves","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2022.07.010_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc14d02s26","article-title":"Gene transfer in the lung using recombinant adeno-associated virus","volume":"26","author":"Gruntman","year":"2012","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.omtm.2022.07.010_bib69","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/s41467-021-21865-2","article-title":"Single cell transcriptomic analysis of murine lung development on hyperoxia-induced damage","volume":"12","author":"Hurskainen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.07.010_bib70","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/dbio.2000.0106","article-title":"Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in\u00a0vivo","volume":"230","author":"Kisanuki","year":"2001","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtm.2022.07.010_bib71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omtm.2022.07.010_bib73","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.it.2013.04.005","article-title":"The innate immune response during liver inflammation and metabolic disease","volume":"34","author":"Bieghs","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omtm.2022.07.010_bib74","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1183\/09031936.01.17201800","article-title":"Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis","volume":"17","author":"Maeyama","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.omtm.2022.07.010_bib76","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1164\/rccm.200810-1615OC","article-title":"Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis","volume":"181","author":"Sisson","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtm.2022.07.010_bib77","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/hum.2017.187","article-title":"Intranasal adeno-associated virus mediated gene delivery and expression of human iduronidase in the central nervous system: a noninvasive and effective approach for prevention of neurologic disease in mucopolysaccharidosis type I","volume":"28","author":"Belur","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.07.010_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2022.05.002","article-title":"Intranasal application of adeno-associated viruses: a systematic review","author":"Gadenstaetter","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.omtm.2022.07.010_bib79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12896-017-0365-2","article-title":"AAV vector distribution in the mouse respiratory tract following four different methods of administration","volume":"17","author":"Santry","year":"2017","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.omtm.2022.07.010_bib80","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41596-018-0097-3","article-title":"Systemic AAV vectors for widespread and targeted gene delivery in rodents","volume":"14","author":"Challis","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2022.07.010_bib81","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.862101","article-title":"Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain","volume":"15","author":"Zhu","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtm.2022.07.010_bib82","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/nn1340","article-title":"GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain","volume":"7","author":"Garcia","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2022.07.010_bib83","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1523\/JNEUROSCI.0760-05.2005","article-title":"Bcl-x is required for proper development of the mouse: substantia nigra","volume":"25","author":"Savitt","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2022.07.010_bib84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmet.2011.01.010","article-title":"Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis","volume":"13","author":"Rossi","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.omtm.2022.07.010_bib85","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2011.05.028","article-title":"Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons","volume":"71","author":"Vong","year":"2011","journal-title":"Neuron"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122001024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122001024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:07:49Z","timestamp":1783638469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050122001024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":85,"alternative-id":["S2329050122001024"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2022.07.010","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2022.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}